BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 2864160)

  • 21. Treatment of depression in bipolar disorder: new directions for research.
    Zornberg GL; Pope HG
    J Clin Psychopharmacol; 1993 Dec; 13(6):397-408. PubMed ID: 8120153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbamazepine as adjunct or alternative to lithium in the prophylaxis of recurrent affective disorders.
    Fritze J; Beneke M; Lanczik M; Schneider B; Walden J
    Pharmacopsychiatry; 1994 Sep; 27(5):181-5. PubMed ID: 7838887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Has drug treatment of manic disorders changed in clinical routine practice? Retrospective analysis of treatment modalities and results in a university psychiatric clinic].
    Reetz-Kokott U; Müller-Oerlinghausen B
    Nervenarzt; 1996 Mar; 67(3):229-34. PubMed ID: 8901281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The lithium concentration of the blood plasma in combined therapy with lithium carbonate and carbamazepine].
    Skorik AI
    Farmakol Toksikol; 1991; 54(4):57-9. PubMed ID: 1786831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological relationships between mania and melancholia.
    Post RM; Uhde TW
    Encephale; 1982; 8(2):213-28. PubMed ID: 6179764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
    Ketter TA
    J Clin Psychiatry; 2008; 69 Suppl 5():9-15. PubMed ID: 19265635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies.
    Zhang ZJ; Kang WH; Li Q; Tan QR
    J Psychiatr Res; 2007 Nov; 41(10):828-36. PubMed ID: 17010995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The use of carbamazepine in affective disorders].
    Beresewicz M
    Psychiatr Pol; 1994; 28(4):455-66. PubMed ID: 7972553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mood disorders in the psychoneurologic borderland: three cases of responsiveness to carbamazepine.
    Kessler AJ; Barklage NE; Jefferson JW
    Am J Psychiatry; 1989 Jan; 146(1):81-3. PubMed ID: 2492164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Valproate in the treatment of bipolar disorder].
    Rzewuska M
    Psychiatr Pol; 2002; 36(2):239-57. PubMed ID: 12043042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clozapine in treatment-refractory mood disorders.
    Kimmel SE; Calabrese JR; Woyshville MJ; Meltzer HY
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():91-3. PubMed ID: 7961583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mood-stabilizing drugs in depression.
    Shelton RC
    J Clin Psychiatry; 1999; 60 Suppl 5():37-40; discussion 41-2. PubMed ID: 10192406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine].
    Dardennes R; Lafuma A; Watkins S
    Encephale; 1999; 25(5):391-400. PubMed ID: 10598301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lithium and carbamazepine therapy in a patient with manic depressive illness: clinical effects, interactions and side effects.
    Klein EM
    Isr J Psychiatry Relat Sci; 1987; 24(4):295-8. PubMed ID: 3505519
    [No Abstract]   [Full Text] [Related]  

  • 35. Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorders.
    Tohen M; Castillo J; Pope HG; Herbstein J
    J Clin Psychopharmacol; 1994 Feb; 14(1):67-70. PubMed ID: 8151006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternative approaches to refractory depression in bipolar illness.
    Post RM; Leverich GS; Denicoff KD; Frye MA; Kimbrell TA; Dunn R
    Depress Anxiety; 1997; 5(4):175-89. PubMed ID: 9338110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical use of carbamazepine in affective disorders.
    Ballenger JC
    J Clin Psychiatry; 1988 Apr; 49 Suppl():13-21. PubMed ID: 3280557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of compliance with lithium and carbamazepine regimens in the long-term treatment of recurrent mood and related psychotic disorders.
    Lenzi A; Lazzerini F; Placidi GF; Cassano GB; Akiskal HS
    Pharmacopsychiatry; 1989 Jan; 22(1):34-7. PubMed ID: 2652160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential response to lithium carbonate in manic depressive and schizo-affective disorders.
    Johnson G
    Dis Nerv Syst; 1970 Sep; 31(9):613-5. PubMed ID: 4919888
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term response to carbamazepine: a retrospective study.
    Frankenburg FR; Tohen M; Cohen BM; Lipinski JF
    J Clin Psychopharmacol; 1988 Apr; 8(2):130-2. PubMed ID: 3372707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.